Recursion Pharmaceuticals, Inc. - RXRX

SEC FilingsOur RXRX Tweets

About Gravity Analytica

Recent News

  • 09.08.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
  • 09.08.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
  • 09.03.2025 - Citi 2025 BioPharma Back to School Conference
  • 09.03.2025 - Citi 2025 BioPharma Back to School Conference
  • 08.27.2025 - Recursion to Participate in Upcoming Investor Conferences
  • 08.27.2025 - Recursion to Participate in Upcoming Investor Conferences
  • 08.05.2025 - Recursion Q2 2025 (L)earnings Call
  • 08.05.2025 - Recursion Q2 2025 (L)earnings Call
  • 08.05.2025 - Recursion Reports Second Quarter 2025 Financial Results and Provides Business Update
  • 08.05.2025 - Recursion Reports Second Quarter 2025 Financial Results and Provides Business Update

Recent Filings

  • 08.26.2025 - 144 Report of proposed sale of securities
  • 08.19.2025 - 4 Statement of changes in beneficial ownership of securities
  • 08.19.2025 - 4 Statement of changes in beneficial ownership of securities
  • 08.19.2025 - 4 Statement of changes in beneficial ownership of securities
  • 08.18.2025 - 144 Report of proposed sale of securities
  • 08.13.2025 - 4 Statement of changes in beneficial ownership of securities
  • 08.11.2025 - 144 Report of proposed sale of securities
  • 08.05.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 08.05.2025 - 8-K Current report
  • 08.05.2025 - EX-99.1 EX-99.1